Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in Cardiogenic Shock
NCT05594342Phase 3Unknown
- Sponsor
- Young Investigator Group of Cardiovascular Research
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in cardiogenic shock, sponsored by Young Investigator Group of Cardiovascular Research. Status: unknown.
02
Drugs
ivabradine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT05594342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594342.